Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized‐controlled trial

Abstract

Nitazoxanide given orally for 14 days was associated with clinical improvement in Zambian acquired immune deficiency syndrome patients with diarrhoea, especially those with very low CD4 counts.